A molecular analysis of vesicular amine transport

Behavioural Brain Research

Volumn 73, Issue 1-2, 1995, Pages 51-58

  Liu, Yongjian ^a   Peter, Doris ^a   Merickel, Andrew ^a   Krantz, David ^a   Finn, J Patrick ^a   Edwards, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamines; Large dense core vesicles; Neurotransmitter packaging; Reserpine; Tetrabenazine; Vesicular monoamine transport

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMPHETAMINE; TETRABENAZINE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; GENE EXPRESSION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SYNAPSE VESICLE;

ANIMALS; BIOGENIC MONOAMINES; HUMANS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 13344270404     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00069-1     Document Type: Article

References (76)

1. Neurotransmitter transporters: recent progress
2. Proton gradient linkage to active uptake of 3H-acetylcholine by Torpedo electric organ synaptic vesicles
3. Effect of psychotropic drugs on the uptake of 3H-norepinephrine by tissues
4. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells
5. Constitutive and regulated secretion of proteins
6. Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system
7. Drugs which block the storage of 5-hydroxytryptamine and related amines
8. Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network
9. Biogenesis of synaptic vesicle-like structures in a pheochromocytoma cell line PC12
10. Monamine oxidase and oxidative stress at dopaminergic synapses
11. Methamphetamine neurotoxicity involves vacuolation of endocytic organells and dopamine-dependent intracellular oxidative stress
12. Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter
13. Pathways to regulated exocytosis in neurons
14. A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
15. The transport of neurotransmitters into synaptic vesicles
16. Expression cloning of a reserpine-sensitive vesicular monoamine transporter
17. Functional identification and molecular cloning of a human brain vesicle monoamine transporter
18. Functional identification of a vesicular acetylcholine transporter and its expression from a ‘cholinergic’ gene locus
19. Mental depression in hypertensive patients treated for long periods with high doses of reserpine
20. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
21. Energy dependence and functional reconstitution of the gamma-aminobutyric acid carrier from synaptic vesicles
22. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules
23. Targeting of the ‘insulin-responsive’ glucose transporter (GLUT4) to the regulated secretory pathway in PC12 cells
24. The uptake of biogenic amines
25. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
26. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
27. Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport
28. Energetics of tetracycline efflux system encoded by Tn10 in Escherichia coli
29. Mechanisms of storage and transport of neurotransmitters
30. +-linked dopamine transport in chromaffin granule ghosts
31. P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT20 cells
32. +) involves binding at the same site as the respiratory inhibitor, rotenone
33. Chronic parkinsonism in humans due to a product of meperidine analog synthesis
34. Pargyline prevents MPTP-induced parkinsonism in primates
35. +
36. + toxicity encodes a vesicular amine transporter
37. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells
38. Vesicle monoamine transporters 1 and 2: differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla
39. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
40. Functional asymmetry of the amine transporter from chromaffin granules
41. Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes
42. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
43. COOH-terminal signals mediate the trafficking of a peptide processing enzyme in endocrine cells
44. Differential trafficking of soluble and integral membrane secretory granule-associated proteins
45. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
46. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system
47. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
48. Effect of deprenyl on the progression of disability in early Parkinson's disease
49. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
50. Chromosomal localization of the human vesicular amine transporter genes
51. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors
52. Newly synthesized synaptophysin is transported to synaptic-like microvesicles via constitutive secretory vesicles and the plasma membrane
53. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells
54. Molecular cloning of a putative vesicular transporter for acetylcholine
55. Catecholamine toxicity in cerebral cortex in dissociated cell culture
56. Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter
57. The molecular mechanism of ‘ecstasy’ [3,4-methylenedioxymethamphetamin (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release
58. p-Chloroamphetamine induces serotonin release through serotonin transporters
59. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters
60. Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding
61. Reserpine binding to a vesicular amine transporter expressed in chinese hamster ovary fibroblasts
62. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters
63. Mechanisms involved in the release of noradrenaline from sympathetic nerve
64. Identification and purification of a function amine transporter from bovine chromaffin granules
65. Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium
66. Proteins of synaptic vesicles involved in exocytosis and membrane recycling
67. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons are chromaffin granules: a mechanism of action
68. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons
69. The human synaptic vesicle monoamine transporter cDNA predict posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs
70. Do environmental toxins cause Parkinson's disease? A critical review
71. Exocytosis from large and small dense core vesicles in noradrenergic nerve terminals
72. Cellular and molecular biology of the presynaptic nerve terminal
73. Cloning and expression of the vesamicol binding protein from the marine Torpedo. Homology with the putative vesicular acetylcholin transporter UNC-17 from Caenorhabditis elegans
74. Identification of a [3H]dihydrote rabenazine-binding protein from bovine adrenal medulla
75. Synaptotagmin: a membrane constituent of neuropeptide-containing large dense-core vesicle
76. Conditions required for reserpine binding to the catecholamine transporter on chromaffin granule ghosts